Accessibility Menu
 
Medpace logo

Medpace

(NASDAQ) MEDP

Current Price$462.84
Market Cap$12.81B
Since IPO (2016)+1,509%
5 Year+172%
1 Year+43%
1 Month+3%

Medpace Financials at a Glance

Market Cap

$12.81B

Revenue (TTM)

$2.53B

Net Income (TTM)

$451.12M

EPS (TTM)

$15.29

P/E Ratio

29.50

Dividend

$0.00

Beta (Volatility)

1.20 (Average)

Price

$462.84

Volume

31,416.014

Open

$460.84

Previous Close

$451.20

Daily Range

$448.29 - $462.84

52-Week Range

$250.05 - $628.92

MEDP: Motley Fool Moneyball Superscore

Our CEO Is Handing Members His Secret Weapon

It's called Motley Fool Moneyball, our new proprietary AI tool

We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.

Get Access Now

About Medpace

Industry

Life Sciences Tools and Services

Employees

6,200

CEO

August James Troendle, MD

Headquarters

Cincinnati, OH 45227, US

MEDP Financials

Key Financial Metrics (TTM)

Gross Margin

30%

Operating Margin

21%

Net Income Margin

18%

Return on Equity

70%

Return on Capital

85%

Return on Assets

23%

Earnings Yield

3.39%

Dividend Yield

0.00%

Payout Ratio

0.00%

Stock Overview

Market Cap

$12.81B

Shares Outstanding

28.38M

Volume

31.42K

Short Interest

0.00%

Avg. Volume

334.59K

Financials (TTM)

Gross Profit

$760.62M

Operating Income

$534.93M

EBITDA

$570.50M

Operating Cash Flow

$713.22M

Capital Expenditure

$31.36M

Free Cash Flow

$681.87M

Cash & ST Invst.

$497.05M

Total Debt

$250.50M

Medpace Performance Analysis

Revenue Growth Rate

Annual and quarterly growth comparison

Earnings Per Share Growth Rate

Annual and quarterly EPS growth comparison

Quarterly Performance

Name
Q4 2025YOY CHG

Revenue

$708.45M

+32.0%

Gross Profit

$205.32M

+15.1%

Gross Margin

28.98%

N/A

Market Cap

$12.81B

N/A

Market Cap/Employee

$2.17M

N/A

Employees

5,900

N/A

Net Income

$135.13M

+15.5%

EBITDA

$163.96M

+23.4%

Quarterly Fundamentals

Name
Q4 2025YOY CHG

Net Cash

$246.55M

-54.6%

Accounts Receivable

$402.08M

+35.6%

Inventory

$0.00

N/A

Long Term Debt

$227.29M

+80.1%

Short Term Debt

$23.21M

N/A

Return on Assets

22.84%

N/A

Return on Invested Capital

84.68%

N/A

Free Cash Flow

$188.12M

+2.8%

Operating Cash Flow

$192.65M

+1.0%

Other Investments to Explore

People Also Watch

Symbol / CompanyPricePrice Chg
SNNSmith & Nephew plc
$31.78+0.44%
CNCCentene Corporation
$32.24+0.77%
THCTenet Healthcare Corporation
$191.60-0.13%
HOLXHologic, Inc.
$75.61-0.07%

Trending Stocks

Symbol / CompanyPricePrice Chg
TQQQProShares Trust - ProShares UltraPro Qqq
$39.10+0.01%
NVDGraniteShares ETF Trust - GraniteShares 2x ShortDA Daily ETF
$8.22-0.01%
ONDSOndas
$8.35-0.05%
TSLLDirexion Shares ETF Trust - Direxion Daily Tsla Bull 2x Shares
$11.72+0.01%

Questions About MEDP

Premium Investing Services

Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.